Merck & Co., Inc. (MRK) — Company Valuation Lab

Period

History

Units

At a glance

FY2025

Missing values remain blank—not zero.

Revenue

Canonical revenue for the selected period.

reported · Revenues

$65.01B

1.3% vs prior

Revenue growth

Change from the comparable prior fiscal period.

derived · year_over_year_growth

1.3%

-5.4 pts vs prior

Gross profit

Revenue less reported cost of revenue when available.

—

Unavailable

Operating income

Income from operations before non-operating items.

—

Unavailable

Net income

Net income attributable under the selected SEC concept.

reported · NetIncomeLoss

$18.25B

6.6% vs prior

Operating cash flow

Cash provided by or used in operating activities.

reported · NetCashProvidedByUsedInOperatingActivities

$16.47B

(23.3%) vs prior

Free cash flow

Operating cash flow less normalized positive CapEx outflow.

derived · operating_cash_flow_minus_capex

$12.36B

(31.7%) vs prior

Cash

Cash and cash equivalents at the period end.

reported · CashAndCashEquivalentsAtCarryingValue

$14.57B

10.0% vs prior

Total debt

Current and noncurrent debt, only when both components exist.

derived · short_term_plus_long_term_debt

$49.05B

32.7% vs prior

Equity

Reported stockholders’ equity at period end.

reported · StockholdersEquity

$52.61B

13.6% vs prior

Diluted shares

Reported weighted-average diluted shares for the period.

reported · WeightedAverageNumberOfDilutedSharesOutstanding

2.51B

(1.3%) vs prior

Gross margin

Gross profit divided by positive revenue.

—

Unavailable

Show additional ratios and quality metrics

Operating margin

Operating income divided by positive revenue.

—

Unavailable

Net margin

Net income divided by positive revenue.

derived · divide

28.1%

+1.4 pts vs prior

FCF margin

Free cash flow divided by positive revenue.

derived · divide

19.0%

-9.2 pts vs prior

3Y revenue CAGR

Compound annual revenue growth over three fiscal years.

derived · three_year_compound_annual_growth

3.1%

-6.5 pts vs prior

Current ratio

Current assets divided by positive current liabilities.

derived · divide

1.54×

12.6% vs prior

Debt / equity

Total debt divided by positive stockholders’ equity.

derived · divide

0.93×

16.8% vs prior

ROIC proxy

NOPAT proxy divided by debt plus equity less cash.

—

Unavailable

FCF consistency

Share of recent observed periods with positive FCF.

—

Unavailable

Revenue and profit trend

Revenue, operating income, and net income on a common scale.

Revenue Operating income Net income

Margin trend

Profitability and cash conversion as a share of revenue.

Gross Operating Net FCF

Cash flow trend

CapEx is shown as a positive investment outflow; FCF equals CFO less CapEx.

Operating cash flow CapEx Free cash flow

Balance sheet trend

Period-end cash, total debt, and stockholders’ equity.

Cash Debt Equity